Mkt Cap$2.33T+1.94%
24h Vol$70.90B
BTC Dom56.6%
ETH Dom9.0%
F&G20Extreme Fear
BTC$65,710.00+1.83% ETH$1,726.94+3.16% USDT$0.9993-0.02% BNB$614.72+0.57% USDC$0.9997-0.01% XRP$1.19+3.62% SOL$71.44+4.47% TRX$0.3197+0.60% FIGR_HELOC$1.02+0.00% HYPE$67.44+10.19% DOGE$0.0885+1.40% USDS$0.9997+0.00% LEO$9.76+0.51% RAIN$0.0135+3.27% ZEC$494.07+16.21% ADA$0.1809+6.23% BTC$65,710.00+1.83% ETH$1,726.94+3.16% USDT$0.9993-0.02% BNB$614.72+0.57% USDC$0.9997-0.01% XRP$1.19+3.62% SOL$71.44+4.47% TRX$0.3197+0.60% FIGR_HELOC$1.02+0.00% HYPE$67.44+10.19% DOGE$0.0885+1.40% USDS$0.9997+0.00% LEO$9.76+0.51% RAIN$0.0135+3.27% ZEC$494.07+16.21% ADA$0.1809+6.23%
News

premarket trading

Total Stories
309
Section
premarket trading
Why Kenvue Stock Is Down in Premarket Today: Trump Team Targets Tylenol–Autism Link
Market Analysis

Why Kenvue Stock Is Down in Premarket Today: Trump Team Targets Tylenol–Autism Link

KVUE shares declined 6% premarket amid reports linking Tylenol to autism risks.

Tim FriesSep 22, 20253 min read